MedPath

Acceptance-Based Treatment for Generalized Anxiety Disorder

Phase 1
Completed
Conditions
Anxiety Disorders
Generalized Anxiety Disorder
Registration Number
NCT00073632
Lead Sponsor
University of Massachusetts, Boston
Brief Summary

This study will develop and implement an awareness- and acceptance-based for treatment of individuals with generalized anxiety disorder.

Detailed Description

Participants in this study are recruited from intakes at the Center for Anxiety and Related Disorders at Boston University. Participants will be randomly assigned to receive either acceptance and mindfulness-based strategies plus cognitive behavioral therapy or no treatment for 16 weeks. The treatment will involve daily practice of mindfulness techniques to help draw attention to and accept various emotional states. Interviews, questionnaires, and depression and anxiety scales will be used to assess participants. Assessments will be conducted post-treatment and at 3- and 9-month follow-up visits.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Generalized Anxiety Disorder (GAD)
  • Willing to maintain medication levels and refrain from any additional psychosocial treatment during the course of the study
Exclusion Criteria
  • Bipolar disorder, psychotic disorder, or substance dependence

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Clinician Severity Rating from ADIS for GADpre, post, 3 mo. f/u, 9 mo. f/u
Penn State Worry Questionnairepre-, post-, 3 mo. f/u, 9 mo. f/u
Depression Anxiety and Stress Scales, anxiety and stress subscalespre-, post-, 3 mo. f/u, 9 mo. f/u
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Center for Anxiety and Related Disorders

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath